Latest Insights on BILI
Buy the Omicron Dip! (But Choose Wisely) December 3, 2021 Big Picture. Big Profits., Investing Markets went haywire this week (and last) in response to a double whammy: Omicron’s appearance on the COVID stage and a suddenly hawkish Fed. Stocks dropped across the board … but some dropped more than others. That confirms what I’ve been saying for most of 2021: The market increasingly prefers quality and consistent earnings growth […]
Are You Confusing RSI and RS? You’re Not Alone… December 3, 2021 Investing, Trading Strategies, True Options Masters Mike Carr clears up decades of confusion over RSI and RS — and reveals which of the two indicators is more likely to beat the market!
Profit From the Metaverse Frenzy in 2022 December 1, 2021 Investment Opportunities, Technology, Winning Investor Daily We’re going to see an explosion in the number of investable opportunities in the metaverse space.
Omicron’s Market Madness, Meta’s Gif Horse & Raptor’s Wreckage November 30, 2021 Great Stuff Don’t Panic & Carry A Towel The market gets to the bottom then goes back to the top of the slide, where it stops and it turns and it goes for a ride … ‘till it gets to the bottom and it does it again! Yeah, yeah, yeah! Do you, don’t you want me to […]
A Stock-Picking Mutation to Beat the Omicron Threat November 30, 2021 Big Picture. Big Profits., Global Economy, News This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.





